---
document_datetime: 2023-12-05 14:01:38
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/finlee-epar-all-authorised-presentations_en.pdf
document_name: finlee-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7571292
conversion_datetime: 2025-12-20 09:06:55.211579
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                             |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------------------|
| EU/1/23/1767/001 | Finlee            | 10 mg      | Dispersible tablet    | Oral use                  | bottle (HDPE)         | 210 tablets + 2 dosing cups           |
| EU/1/23/1767/002 | Finlee            | 10 mg      | Dispersible tablet    | Oral use                  | bottle (HDPE)         | 420 (2 x 210) tablets + 2 dosing cups |